Core Viewpoint - Ardent Health, Inc. is facing a securities class action lawsuit due to allegations of misleading investors regarding its revenue recognition systems and professional liability reserves, leading to significant financial repercussions for the company [1] Allegations of the Class Action - The lawsuit claims that Ardent Health misrepresented its financial health, resulting in a nearly 34% stock price drop following disclosures made on November 12, 2025 [1] - A $54 million increase in professional liability reserves was recorded, attributed to recent settlements and ongoing litigation, as well as broader industry trends such as social inflation [1] - Ardent Health disclosed a revenue reduction of $42.6 million due to a change in accounting methods for estimating the collectability of accounts receivable [1] - The company allegedly did not maintain sufficient professional malpractice liability insurance and had inadequate professional liability reserves [1] - The complaint highlights that Ardent's method of using a "180-day cliff" for reserves contradicted its claims of conducting "detailed reviews" of receivables, suggesting inflated receivables during the class period [1] Next Steps for Investors - Investors who purchased Ardent Health shares between July 18, 2024, and November 12, 2025, are encouraged to contact the law firm Hagens Berman, with a lead plaintiff deadline set for March 9, 2026 [1]
INVESTOR ALERT: Ardent Health (ARDT) Investors with Substantial Losses Have Opportunity to Lead Ardent Health Securities Class Action